|
1.Mastroeni P, Chabalgoity JA, Dunstan SJ, Maskell DJ, Dougan G. 2001. Salmonella: immune responses and vaccines. Vet J. 161:132-64. 2.Chiu CH, Su LH, Chu C. 2004. Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment. Clin Microbiol Rev 17: 311-22. 3.Cheminay C, Hensel M. 2008. Rational design of Salmonella recombinant vaccines. Int J Med Microbiol 298:87-98. 4.Nugraha J, Marpaung FR, Tam FC, Lim PL. 2012. Microbiological culture simplified using anti-O12 monoclonal antibody in TUBEX test to detect Salmonella bacteria from blood culture broths of enteric fever patients. PloS One 7: e49586. 5.Schroeder HW Jr, Cavacini L. 2010. Structure and function of immunoglobulins. J Allergy Clin Immunol 125:S41-52. 6.Nesargikar PN, Spiller B, Chavez R. 2012. The complement system: history, pathways, cascade and inhibitors. Eur J Microbiol Immunol 2:103-11. 7.Casadevall A, Pirofski LA. 2003. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol 24:474-8. 8.Reverberi R, Reverberi L. 2007. Factors affecting the antigen-antibody reaction. Blood Transfus 5:227-40. 9.Siddiqui MZ. 2010. Monoclonal antibodies as diagnostics; an appraisal. Indian J Pharm Sci 72:12-7. 10.Saylor C, Dadachova E, Casadevall A. 2009. Monoclonal antibody-based therapies for microbial diseases. Vaccine 27 Suppl 6:G38-46. 11.Hsiung L, Barclay AN, Brandon MR, Sim E, Porter RR. 1982. Purification of human C3b inactivator by monoclonal-antibody affinity chromatography. Biochem J 203:293-8. 12.Baum T, Hiatt A, Parrott W, Pratt L, Hussey R. 1996. Expression in tobacco of a functional monoclonal antibody specific to stylet secretions of the root-knot nematode. MPMI 9:382-7. 13.Takahashi T, Yamaguchi T, Kitamura K, Suzuyama H, Honda M, Yokota T, Kotanagi H, Takahashi M, Hashimoto Y. 1988. Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma. Cancer 61:881-8. 14.Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, et al. 1994. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-10. 15.Kohler G, Milstein C. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-7. 16.Shulman M, Wilde CD, Kohler G. 1978. A better cell line for making hybridomas secreting specific antibodies. Nature 276:269-70. 17.de StGroth SF, Scheidegger D. 1980. Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 35:1-21. 18.Smith GP. 1985. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315-7. 19.Gai SA, Wittrup KD. 2007. Yeast surface display for protein engineering and characterization. Curr Opin Struct Biol 17:467-73. 20.Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. 1991. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222:581-97. 21.Hoogenboom HR. 1997. Designing and optimizing library selection strategies for generating high-affinity antibodies. Trends Biotechnol 15:62-70. 22.Jeong KJ, Jang SH, Velmurugan N. 2011. Recombinant antibodies: engineering and production in yeast and bacterial hosts. Biotechnol J 6:16-27. 23.Joosten V, Lokman C, Van Den Hondel CA, Punt PJ. 2003. The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Microb Cell Fact 2:1-1. 24.Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P, Strauss M. 1995. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci U S A 92:10099-103. 25.Wurm FM. 2004. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22:1393-8. 26.Daniell H, Streatfield SJ, Wycoff K. 2001. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 6: 219-26. 27.Houdebine LM. 2009. Production of pharmaceutical proteins by transgenic animals. Comp Immunol Microbiol Infect Dis 32:107-21. 28.Vezina LP, Faye L, Lerouge P, D'Aoust MA, Marquet-Blouin E, Burel C, Lavoie PO, Bardor M, Gomord V. 2009. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol J 7: 442-55. 29.Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593-656. 30.Confer AW, Ayalew S. 2013. The OmpA family of proteins: roles in bacterial pathogenesis and immunity. Vet Microbiol 163:207-22. 31.Smith SG, Mahon V, Lambert MA, Fagan RP. 2007. A molecular Swiss army knife: OmpA structure, function and expression. FEMS Microbiol Lett 273:1-11. 32.Chalifour A, Jeannin P, Gauchat JF, Blaecke A, Malissard M, N'Guyen T, Thieblemont N, Delneste Y. 2004. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 104: 1778-83. 33.Jeannin P, Magistrelli G, Goetsch L, Haeuw JF, Thieblemont N, Bonnefoy JY, Delneste Y. 2002. Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies. Vaccine 20 Suppl 4:A23-7. 34.Van Regenmortel MH, Pellequer JL. 1994. Predicting antigenic determinants in proteins: looking for unidimensional solutions to a three-dimensional problem? Pept Res 7:224-8. 35.Ortiz-Suarez ML, Samsudin F, Piggot TJ, Bond PJ, Khalid S. 2016. Full-length OmpA: structure, function, and membrane interactions predicted by molecular dynamics simulations. Biophys J 111:1692-1702. 36.Manning M, Colon W. 2004. Structural basis of protein kinetic stability: resistance to sodium dodecyl sulfate suggests a central role for rigidity and a bias toward beta-sheet structure. Biochemistry 43:11248-54. 37.Lee CH, Wu CL, Tai YS, Shiau AL. 2005. Systimic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy. Mol Ther 11:707-16. 38.Sharon J, Sompuram SR, Yang CY, Williams BR, Sarantopoulos S. 2002. Construction of polyclonal antibody libraries using phage display. Methods Mol Biol 178:101-12.
|